Literature DB >> 15512724

Pulmonary function after surfactant lung lavage followed by surfactant administration in infants with severe meconium aspiration syndrome.

M Szymankiewicz1, J Gadzinowski, K Kowalska.   

Abstract

OBJECTIVE: The effect of surfactant lung lavage (SLL) on pulmonary function was examined in neonates with severe form of meconium aspiration syndrome (MAS) (mean +/- standard deviation: birth weight, 3178.1 +/- 237.6 g; gestational age, 37.7 +/- 1.8 weeks).
METHODS: The infants were on mechanical ventilation and were subjected to SLL with Survanta. Dynamic compliance (Cdyn), airway resistance (Raw) and mean airway pressure (MAP) were obtained with use of the pneumotachometric method. Measurements of Cdyn, Raw, MAP and time constant (Tc) were compared in the study and control groups and between the groups before SLL and 24 and 48 h after SLL.
RESULTS: A significant increase in Cdyn (from 1.06 +/- 0.23 to 2.12 +/- 0.99 (ml/cmH(2)O)/kg) (p < 0.05) and a drop in both Raw (from 264.7 +/- 41.5 to 146.6 +/- 39.4 (cmH(2)O/l)/s) and MAP (from 12.4 +/- 3.6 to 5.4 +/- 2.1 cmH(2)O) were observed 48 hours after SLL.
CONCLUSIONS: These data suggest that SLL is associated with a rapid and significant improvement in pulmonary mechanics, together with an improvement in oxygenation, in newborns with severe MAS. We found that the beneficial effects of SLL on pulmonary mechanics persisted for at least 48 h after introduction of the procedure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512724     DOI: 10.1080/14767050400003777

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

Review 1.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Bronchoalveolar lavage with diluted porcine surfactant in mechanically ventilated term infants with meconium aspiration syndrome.

Authors:  Gianluca Lista; Silvia Bianchi; Francesca Castoldi; Paola Fontana; Francesco Cavigioli
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 3.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08

Review 4.  An Official American Thoracic Society/European Respiratory Society Workshop Report: Evaluation of Respiratory Mechanics and Function in the Pediatric and Neonatal Intensive Care Units.

Authors:  Stacey Peterson-Carmichael; Paul C Seddon; Ira M Cheifetz; Inéz Frerichs; Graham L Hall; Jürg Hammer; Zoltán Hantos; Anton H van Kaam; Cindy T McEvoy; Christopher J L Newth; J Jane Pillow; Gerrard F Rafferty; Margaret Rosenfeld; Janet Stocks; Sarath C Ranganathan
Journal:  Ann Am Thorac Soc       Date:  2016-02

5.  Respiratory support in meconium aspiration syndrome: a practical guide.

Authors:  Peter A Dargaville
Journal:  Int J Pediatr       Date:  2012-02-23

6.  Early cardiac injury in acute respiratory distress syndrome: comparison of two experimental models.

Authors:  P Mikolka; P Kosutova; S Balentova; D Cierny; J Kopincova; M Kolomaznik; M Adamkov; A Calkovska; D Mokra
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.